Transforming Lives in Alcohol-Associated Liver Disease: Early Detection, Equitable Treatment, and Inclusive Research Strategies 

Description

This session on alcohol-associated liver disease (ALD) provides a comprehensive overview from both patient and physician perspectives, emphasizing early detection, equitable access to treatment, and inclusive research practices. The session includes a patient sharing their experiences, highlighting the physical and emotional challenges of living with ALD and the importance of support systems. Physicians discuss early detection, detailing diagnostic tools and the benefits of early intervention. They also address how disparities influence access to liver transplantation and clinical trial opportunities, and propose strategies that center on equity. After the individual presentations, a panel of speakers answer questions from the audience and engage in a dialogue about the future directions in ALD detection, treatment, and research. 

Journey Maps

Presentations

2:00 PM - 2:15 PM
Nov 07 2025
San Diego, CA

Living With Alcohol-Associated Liver Disease: A Patient's Perspective

Stephen Silva-Brave, MSW, Presenter
ALD
Patient Program
2:15 PM - 2:30 PM
Nov 07 2025
San Diego, CA

Early Detection of Alcohol-Associated Liver Disease: A Clinician's Perspective

Erin Cleveland, MD, Presenter
ALD
Patient Program
2:30 PM - 2:45 PM
Nov 07 2025
San Diego, CA

Early Transplantation for Alcohol-Associated Liver Disease: Bridging Gaps in Access and Equity

Juan Pablo Arab, MD, FRCPC, Presenter
ALD
Patient Program
2:45 PM - 3:00 PM
Nov 07 2025
San Diego, CA

Clinical Trials in Alcohol-Associated Liver Disease: Enhancing Participation, Diversity, and Trust

Lamia Y. Haque, MD, MPH, Presenter
ALD
Patient Program

Objectives

  • Review the importance of early detection and intervention for managing alcohol-associated liver disease (ALD).
  • List the tools and methods available for early detection of ALD.
  • State the benefits of timely treatment for ALD.
  • Discuss the importance of equitable access to treatment, including liver transplantation.
  • Review strategies to improve equity and inclusivity through policy changes, community outreach, and diverse participation in research.